The Prevalence of and Factors Associated with Potentially Inappropriate Medications Use in The...
-
Upload
gervais-king -
Category
Documents
-
view
215 -
download
1
Transcript of The Prevalence of and Factors Associated with Potentially Inappropriate Medications Use in The...
The Prevalence of and Factors Associated with Potentially Inappropriate Medications Use in The
Elderly Population in Thailand
Rosarin Sruamsiri1, Nathorn Chaiyakunapruk1, Napawan Jeanpeerapong2
1Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences,
Naresuan University, Phitsanulok, Thailand2Department of Pharmacy, Bhuddhachinaraj Hospital, Muang, Phitsanulok, Thailand
The Prevalence of and Factors Associated with Potentially Inappropriate Medications Use in The
Elderly Population in Thailand
Rosarin Sruamsiri1, Nathorn Chaiyakunapruk1, Napawan Jeanpeerapong2
1Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences,
Naresuan University, Phitsanulok, Thailand2Department of Pharmacy, Bhuddhachinaraj Hospital, Muang, Phitsanulok, Thailand
1
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Background
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
• Elderly people are vulnerable to medical misadventures.
• Inappropriate used of medications is considered one of the main causes of adverse drug reactions in the elderly.
• Jano E and Aparasu RR. Healthcare outcomes associated with beers’ criteria: a systematic review. Ann Phamacother. 2007; 41: 438-48• Page et al. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions.Clinical Intervention in Aging.2010;5:75-87
2
Background
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
• Risk of drug-drug interactions
3
• Cost of drug-related morbidity and mortality : $76.6 billion annually.
• Incremental healthcare costs related to inappropriate prescribing in older : $7.2 billion annually.
Pro
ba
bili
ty o
f h
avin
g
dru
g-d
rug
inte
ract
ion
• Goldberg R, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high risk population. Am J Emerg Med. 1996;14(5):447-450.• Johnson J, Bootman J. Drug-related morbidity and mortality: a cost-of-illness model. Archives of Internal Medicine. 1995;155:1949-1956.• Fu A, Jiang J, Reeves J, Fincham J, Liu G, Perri MI. Potentially inappropriate medication use and healthcare expenditures in the US community dwelling elderly. Medical Care. 2007;45:472–476.
• Goldberg R, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high risk population. Am J Emerg Med. 1996;14(5):447-450.• Johnson J, Bootman J. Drug-related morbidity and mortality: a cost-of-illness model. Archives of Internal Medicine. 1995;155:1949-1956.• Fu A, Jiang J, Reeves J, Fincham J, Liu G, Perri MI. Potentially inappropriate medication use and healthcare expenditures in the US community dwelling elderly. Medical Care. 2007;45:472–476.
4
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Background• “Potentially Inappropriate Medications”(PIMs) or
“Potentially Inappropriate Prescriptions”
O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Aging. 2008 Mar; 37(2):138-41.
Medications that have no clear evidence-based indication, carry a substantially higher risk of adverse side-effect or not cost-effective.
5
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Background Prevalence of PIMs ranged from 5.8% to 51.4% in various settings
and countries.
• Aparasu R, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother. 2003;34:338-346.•F ialová D, Topinková E, Gambassi G, al e. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–1358.• Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113-121.
• Aparasu R, Mort J. Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother. 2003;34:338-346.•F ialová D, Topinková E, Gambassi G, al e. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293:1348–1358.• Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113-121.
6
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Specific criteria for avoidable PIMs has later been developed in the USA, Canada, France, Ireland and Norway.
A list of PIMs called ‘the criteria for high-risk medications use in Thai older patients’ was developed in 2008.
Background
•Fick D, Cooper J, Wadw W, Waller J, Maclean R, Beers M. Updating the Beers criteria for potentially inappropriate medication use in older adults: result of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.•McLeod P, Huang A, Tamblyn R, Gayton D. Defining inappropriate practices in prescribing for eldely peoplr: a national consensus panel. Can Med Assoc J. 1997;156:385-391.•Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(725-731).•Gallanher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP(Screening Tool of Older Person's Prescription) and START (Screening Tool to Alert doctors to Right Treatment).Consensus validation. Int J Clin Pharmacol Ther. 2008;46(72-83).•Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller T, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study. Scan J Prim Health Care. 2009;27:153-159.
•Fick D, Cooper J, Wadw W, Waller J, Maclean R, Beers M. Updating the Beers criteria for potentially inappropriate medication use in older adults: result of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-2724.•McLeod P, Huang A, Tamblyn R, Gayton D. Defining inappropriate practices in prescribing for eldely peoplr: a national consensus panel. Can Med Assoc J. 1997;156:385-391.•Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(725-731).•Gallanher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP(Screening Tool of Older Person's Prescription) and START (Screening Tool to Alert doctors to Right Treatment).Consensus validation. Int J Clin Pharmacol Ther. 2008;46(72-83).•Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller T, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: A modified Delphi study. Scan J Prim Health Care. 2009;27:153-159.
7
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Understanding the epidemiology of PIMs among elderly population could enable clinicians to properly develop measures to maximize benefits of drug use and minimize adverse drug events
It is important to examine the prevalence of and identify factors associated with PIMs in Thailand.
Background
8
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
To determine the prevalence of PIMs in the Thai elderly population.
To identify factors associated with PIMs
Objectives
MethodsMethods
9
10
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Retrospective databases analysis– Databases from a university-affiliated hospital
• Out-patient diagnosis databases• Pharmacy databases
– Inclusion criteria• Patients aged ≥ 65 year-old• Patients visited the outpatient department in 2008
– PIMs evaluation• The criteria for high-risk medication use in Thai older
patients (Winit-Watjana et al 2008)– Analysis
• Descriptive statistics for prevalence of PIMs• Multivariate analysis using generalized estimation
equations (GEE) to determine factors associated with PIMs
Methods
11
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Methods The criteria for high-risk medication use in Thai older patients (Winit-Watjana et al 2008)
– Categorized into 3 categories
– 4 severities classification
Categories Examples
High-risk medications • Diazepam
Drug-disease interactions • Peptic Ulcer and NSAIDs*
Drug-drugs interactions • Warfarin and NSAIDs*
* NSAIDs : Non-Steroidal anti-inflammatory drug
Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr2008 Jul-Aug;47(1):35-51.
Severity Description
1 drug or pair should be avoid
2 drug or pair rarely appropriate
3 drug or pair with some indications for elderly patients
UC un-classified
ResultsResults
12
13
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Characteristics Total n (%)
Total 14,994Age mean(SD) 73 (6.6) 65-74 9,360 (62.42) 75-84 4,810 (32.08) ≥85 824 (5.50)Sex Male 6,533 (43.57) Female 8,461 (56.43)Status of treatment Universal Coverage (UC) 7,532 (50.23) Social Security Scheme (SSS) 46 (0.31) Civil Servants Medical Benefit Scheme (CSMBS) 7,347 (49.00) Others 69 (0.46)
Results
14
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Results
58% (8,676/14,994) of included patients were prescribed at least 1 PIMs.
Of 8,676 PIMs users
4 % received drug or pair should be avoid.
8 % received drug or pair rarely appropriate
29 % received drug or pair with some indications for elderly patients
59% unclassified
15
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Results Table 1. The Most Common Potentially Inappropriate Medications (PIMs) Use among
Elderly Thai Patients
*Classification of high-risk medication use: 1= drug or pair should be avoid; 2= drug or pair rarely appropriate; 3= drug or pair with some indications for elderly patients; UC=un-classified.
High- risk medication used criteria Classification* Prevalence in year 2008 (%)
Medications
NSAIDs 2 1,492/8,676 (17.2)
NSAIDs, COX II inhibitors 2 651/8,676 (7.5)
ACEIs 3 2,605/8,676 (30.0)
Short-acting Benzodiazepines 3 1,732/8,676 (20.0)
Alpha-blockers 3 1,061/8,676 (12.2)
Drug-Disease Interactions
Peptic ulcer-NSAIDs 1 64/8,676 (0.7)
Glaucoma-tricyclic antidepressant 1 30/8,676 (0.3)
Coronary artery disease – testosterone 3 83/8,676 (1.0)
Drug-Drug Interactions
Aspirin-NSAIDs 1 214/8,676 (2.5)
Warfarin-NSAIDs 1 81/8,676 (0.9)
16
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
ResultsFactors associated with PIMs
Individual factorso Polypharmacy
6-9 medications: OR, 3.32 (3.17 – 3.48)≥ 10 medications: OR, 6.94 (6.39– 7.53) compared with patients taking ≤
5 medications. o Higher morbidities:
CCI* score 2-3: OR, 5.04 (4.69 – 5.51) CCI* score >4: OR, 8.78 (8.86 – 8.90) compared with CCI score of 0-1
System factorso Universal Coverage (UC): OR, 1.77 (1.72 – 1.82) compared with CSMBSo Prescribers under training: OR, 1.95 (1.81-2.11)o Prescribers working in the department of psychiatry: OR, 3.46 (3.01-3.98)
Conclusions & Conclusions & ImplicationsImplications
17
Conclusions
18
Using country’s specific criteria can determine the magnitude of problem in local context.
PIMs used among elderly remains a major public health concern in Thailand.
Both individual characteristics and health system factors were associated with PIMs.
Proper managements are needed especially among those with co-morbidities and receiving muli-medications.
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
19
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Implications Further researches are needed to target extended,
clinical practices and policy implementations to reduce PIMs.
Reduction strategies should be implemented from both bottom-up and top-down.
20
Acknowledgement Our research team:
• Dr. Nathorn Chiyakunapruk
• Napawan Jeanpeerapong
World Health Organization
Thailand Research Fund through the Royal Golden Jubilee PhD
program
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011
Rosarin Sruamsiri, B.Pharm , M.B.A.Center for Pharmaceutical Outcomes Research (CPOR)
Faculty of Pharmaceutical SciencesNaresuan University
Muang, Phitsanulok, Thailand 65000 [email protected]
Rosarin Sruamsiri, B.Pharm , M.B.A.Center for Pharmaceutical Outcomes Research (CPOR)
Faculty of Pharmaceutical SciencesNaresuan University
Muang, Phitsanulok, Thailand 65000 [email protected]
Contact informationContact information
21
Third International Conference for Improving Use of Medicines, Antalya, Turkey, November 14-18,2011